Skip to main content
. 2021 May 17;13(10):2424. doi: 10.3390/cancers13102424

Figure 3.

Figure 3

Short progression free survival (PFS < 21 months, n = 15) compared to long progression free survival (PFS > 21 months, n = 15) for patients with metastases at diagnosis. The relative gene expression levels of S100A9 (a) and S100A12 (b), and monocyte count (c) are illustrated by box plots. Outlier values (o) and significant p-values from the Mann–Whitney U tests are indicated.